Macquarie Group’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-101,676
| Closed | -$2.59M | – | 942 |
|
|
2025
Q3 | $2.59M | Sell |
101,676
-2,001
| -2% | -$47.5K | ﹤0.01% | 1102 |
|
|
2025
Q2 | $2.23M | Sell |
103,677
-1,262
| -1% | -$28.4K | ﹤0.01% | 1188 |
|
|
2025
Q1 | $2.4M | Sell |
104,939
-2,426
| -2% | -$63.9K | ﹤0.01% | 1168 |
|
|
2024
Q4 | $2.79M | Buy |
107,365
+12,240
| +13% | +$305K | ﹤0.01% | 1088 |
|
|
2024
Q3 | $2.38M | Buy |
95,125
+650
| +0.7% | +$15.4K | ﹤0.01% | 1177 |
|
|
2024
Q2 | $2.02M | Sell |
94,475
-109
| -0.1% | -$2.12K | ﹤0.01% | 1218 |
|
|
2024
Q1 | $1.75M | Sell |
94,584
-1,649
| -2% | -$28.8K | ﹤0.01% | 1262 |
|
|
2023
Q4 | $1.56M | Buy |
96,233
+13,995
| +17% | +$179K | ﹤0.01% | 1289 |
|
|
2023
Q3 | $1.14M | Buy |
82,238
+1,604
| +2% | +$25.3K | ﹤0.01% | 1317 |
|
|
2023
Q2 | $1.78M | Buy |
80,634
+12,317
| +18% | +$259K | ﹤0.01% | 1212 |
|
|
2023
Q1 | $1.49M | Buy |
68,317
+12,644
| +23% | +$284K | ﹤0.01% | 1254 |
|
|
2022
Q4 | $1.01M | Sell |
55,673
-18,728
| -25% | -$387K | ﹤0.01% | 1412 |
|
|
2022
Q3 | $1.7M | Buy |
74,401
+964
| +1% | +$20.6K | ﹤0.01% | 1280 |
|
|
2022
Q2 | $1.01M | Buy |
73,437
+766
| +1% | +$11.2K | ﹤0.01% | 1477 |
|
|
2022
Q1 | $1.65K | Buy |
72,671
+2,307
| +3% | +$60.7K | ﹤0.01% | 1419 |
|
|
2021
Q4 | $2.62M | Buy |
70,364
+69,769
| +11,726% | +$2.99M | ﹤0.01% | 1292 |
|
|
2021
Q3 | $25K | Hold |
595
| – | – | ﹤0.01% | 2400 |
|
|
2021
Q2 | $26K | Buy |
+595
| New | +$21K | ﹤0.01% | 2305 |
|
|
2018
Q4 | – | Sell |
-600
| Closed | -$10K | – | 2253 |
|
|
2018
Q3 | $10K | Sell |
600
-7,100
| -92% | -$140K | ﹤0.01% | 1994 |
|
|
2018
Q2 | $88K | Buy |
+7,700
| New | +$70.1K | ﹤0.01% | 1867 |
|
|
2018
Q1 | – | Sell |
-5,600
| Closed | -$34K | – | 2192 |
|
|
2017
Q4 | $34K | Buy |
+5,600
| New | +$32.3K | ﹤0.01% | 2057 |
|
Other funds holding BLFS
CC
FAM
